Impact of elevated serum glycated albumin levels on contrast-induced acute kidney injury in diabetic patients with moderate to severe renal insufficiency undergoing coronary angiography

International Journal of Cardiology

Volumn 167, Issue 2, 2013, Pages 369-373

  Ding, Feng Hua ^a   Lu, Lin ^a   Zhang, Rui Yan ^a   Zhu, Tian Qi ^a   Pu, Li Jin ^a   Zhang, Qi ^a   Chen, Qiu Jing ^a   Hu, Jian ^a   Yang, Zhen Kun ^a   Shen, Wei Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Contrast media; Contrast induced acute kidney injury; Diabetes mellitus; Glycated albumin; Glycosylated hemoglobin A1c; Renal insufficiency

Indexed keywords

CREATININE; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

ACUTE KIDNEY FAILURE; AGE; AGED; ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR DISEASE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; DIABETIC PATIENT; DIALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SEX;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX;

EID: 84879111682     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.12.101     Document Type: Article

References (38)

1. P.A. McCullough Contrast-induced acute kidney injury J Am Coll Cardiol 51 2008 1419 1428
2. K. Nash, A. Hafeez, and S. Hou Hospital-acquired renal insufficiency Am J Kidney Dis 39 2002 930 936
3. G. Dangas, I. Iakovou, and E. Nikolsky Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables Am J Cardiol 95 2005 13 19
4. B. Holscher, C. Heitmeyer, M. Fobker, G. Breithardt, R.M. Schaefer, and H. Reinecke Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial Can J Cardiol 24 2008 845 850
5. I. Iakovou, G. Dangas, and R. Mehran Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention J Invasive Cardiol 15 2003 18 22
6. R. Mehran, E.D. Aymong, and E. Nikolsky A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation J Am Coll Cardiol 44 2004 1393 1399
7. S.H. Jo, T.J. Youn, and B.K. Koo Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial J Am Coll Cardiol 48 2006 924 930
8. P.A. McCullough, A. Adam, and C.R. Becker Risk prediction of contrast-induced nephropathy Am J Cardiol 98 2006 27K 36K
9. A. Caixeta, and R. Mehran Evidence-based management of patients undergoing PCI: contrast-induced acute kidney injury Catheter Cardiovasc Interv 75 Suppl 1 2010 S15 S20
10. R. Mehran, E. Nikolsky, and A.J. Kirtane Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study JACC Cardiovasc Interv 2 2009 415 421
11. O. Toprak, M. Cirit, and M. Yesil Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease Nephrol Dial Transplant 22 2007 819 826
12. J.M. Stolker, P.A. McCullough, and S. Rao Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography J Am Coll Cardiol 55 2010 1433 1440
13. D. Yoshikawa, S. Isobe, and K. Sato Importance of oral fluid intake after coronary computed tomography angiography: an observational study Eur J Radiol 77 2011 118 122
14. T. Kouzuma, Y. Uemastu, T. Usami, and S. Imamura Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method Clin Chim Acta 346 2004 135 143
15. S. Takahashi, H. Uchino, and T. Shimizu Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control Endocr J 54 2007 139 144
16. M. Inaba, S. Okuno, and Y. Kumeda Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection J Am Soc Nephrol 18 2007 896 903
17. L.J. Pu, L. Lu, and X.W. Xu Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes Cardiovasc Diabetol 5 2006 27
18. L. Lu, L.J. Pu, and X.W. Xu Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus Clin Biochem 40 2007 810 816
19. L. Lu, L.J. Pu, and Q. Zhang Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes Atherosclerosis 206 2009 540 545
20. C.G. Schalkwijk, N. Chaturvedi, H. Twaafhoven, H.V.W. van, and C.D. Stehouwer Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients Eur J Clin Invest 32 2002 500 506
21. M.P. Cohen, E. Hud, E. Shea, and C.W. Shearman Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice Metabolism 51 2002 901 905
22. M.P. Cohen, F.N. Ziyadeh, and S.W. Hong Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-beta1 Kidney Int 61 2002 2025 2032
23. Standards of medical care in diabetes - 2010 Diabetes Care 33 Suppl. 1 2010 S11 S61
24. Y.C. Ma, L. Zuo, and J.H. Chen Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease J Am Soc Nephrol 17 2006 2937 2944
25. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) JAMA 285 2001 2486 2497
26. G. Lippi, and G. Targher Glycated hemoglobin (HbA1c): old dogmas, a new perspective Clin Chem Lab Med 48 2010 609 614
27. M. Koga, and S. Kasayama Clinical impact of glycated albumin as another glycemic control marker Endocr J 57 2010 751 762
28. R.Y. Zhang, Z.B. Zhu, and Q. Zhang Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention Int J Cardiol 136 2009 72 79
29. O. Toprak What is the best definition of contrast-induced nephropathy Ren Fail 29 2007 387 388
30. F.N. Ziyadeh, and M.P. Cohen Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy Mol Cell Biochem 125 1993 19 25
31. R.E. Cronin Contrast-induced nephropathy: pathogenesis and prevention Pediatr Nephrol 25 2010 191 204
32. A. Pflueger, D. Abramowitz, and A.D. Calvin Role of oxidative stress in contrast-induced acute kidney injury in diabetes mellitus Med Sci Monit 15 2009 RA125 RA136
33. J.A. Scott, and G.L. King Oxidative stress and antioxidant treatment in diabetes Ann N Y Acad Sci 1031 2004 204 213
34. B.P. Oberg, E. McMenamin, and F.L. Lucas Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease Kidney Int 65 2004 1009 1016
35. S.N. Heyman, S. Rosen, M. Khamaisi, J.M. Idee, and C. Rosenberger Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy Invest Radiol 45 2010 188 195
36. Y. Hattori, N. Banba, S.S. Gross, and K. Kasai Glycated serum albumin-induced nitric oxide production in vascular smooth muscle cells by nuclear factor kappaB-dependent transcriptional activation of inducible nitric oxide synthase Biochem Biophys Res Commun 259 1999 128 132
37. M.P. Cohen, E. Shea, S. Chen, and C.W. Shearman Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells J Lab Clin Med 141 2003 242 249
38. F.H. Artunc, I.U. Fischer, T. Risler, and C.M. Erley Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization Int J Cardiol 102 2005 173 178